Free Trial

Brokers Offer Predictions for Globe Life FY2026 Earnings

Globe Life logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • DOWLING & PARTN raised its FY2026 EPS estimate for Globe Life to $15.80, slightly above the current consensus of $15.57, and also projected $16.40 for FY2027 and $18.10 for FY2028.
  • Globe Life’s latest quarterly results were mixed: it posted $3.43 EPS, missing estimates by a small margin, while revenue came in line at $1.56 billion and rose 5.3% year over year. The company also guided FY2026 EPS to $15.40-$15.90.
  • Sentiment remains broadly positive, with the stock carrying a Moderate Buy rating and an average target price of $174.11. However, recent insider selling, including share sales by the CEO and EVP, was notable.
  • MarketBeat previews top five stocks to own in June.

Globe Life Inc. (NYSE:GL - Free Report) - Equities research analysts at DOWLING & PARTN issued their FY2026 earnings per share (EPS) estimates for shares of Globe Life in a report issued on Wednesday, May 20th. DOWLING & PARTN analyst J. Hurwitz anticipates that the company will earn $15.80 per share for the year. The consensus estimate for Globe Life's current full-year earnings is $15.57 per share. DOWLING & PARTN also issued estimates for Globe Life's FY2027 earnings at $16.40 EPS and FY2028 earnings at $18.10 EPS.

GL has been the subject of several other reports. Weiss Ratings upgraded Globe Life from a "buy (b-)" rating to a "buy (b)" rating in a research report on Wednesday, May 13th. JPMorgan Chase & Co. upped their price objective on Globe Life from $180.00 to $181.00 and gave the stock an "overweight" rating in a research report on Thursday, February 5th. Piper Sandler upped their price objective on Globe Life from $167.00 to $175.00 and gave the stock an "overweight" rating in a research report on Tuesday. Morgan Stanley upped their price objective on Globe Life from $176.00 to $181.00 and gave the stock an "overweight" rating in a research report on Thursday, May 21st. Finally, Texas Capital upgraded Globe Life to a "strong-buy" rating in a research report on Wednesday, March 18th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $174.11.

Check Out Our Latest Analysis on Globe Life

Globe Life Price Performance

Shares of GL stock opened at $154.39 on Thursday. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38. Globe Life has a twelve month low of $116.73 and a twelve month high of $157.92. The company has a market cap of $11.99 billion, a P/E ratio of 10.68 and a beta of 0.50. The business has a fifty day simple moving average of $148.25 and a 200 day simple moving average of $142.48.

Globe Life (NYSE:GL - Get Free Report) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing the consensus estimate of $3.46 by ($0.03). Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The business had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the prior year, the company earned $3.07 earnings per share. Globe Life's quarterly revenue was up 5.3% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS.

Hedge Funds Weigh In On Globe Life

Large investors have recently bought and sold shares of the company. Hilton Head Capital Partners LLC bought a new position in Globe Life in the fourth quarter valued at about $30,000. CYBER HORNET ETFs LLC acquired a new stake in shares of Globe Life in the second quarter valued at about $28,000. MUFG Securities EMEA plc acquired a new stake in shares of Globe Life in the second quarter valued at about $31,000. Torren Management LLC acquired a new stake in shares of Globe Life in the fourth quarter valued at about $37,000. Finally, AdvisorNet Financial Inc increased its stake in shares of Globe Life by 41.1% in the first quarter. AdvisorNet Financial Inc now owns 316 shares of the company's stock valued at $44,000 after buying an additional 92 shares during the period. 81.61% of the stock is currently owned by institutional investors.

Insider Transactions at Globe Life

In other Globe Life news, CEO Frank M. Svoboda sold 20,000 shares of the stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $156.68, for a total value of $3,133,600.00. Following the completion of the transaction, the chief executive officer directly owned 54,020 shares in the company, valued at approximately $8,463,853.60. This trade represents a 27.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael Clay Majors sold 34,000 shares of the stock in a transaction dated Friday, April 24th. The shares were sold at an average price of $153.81, for a total value of $5,229,540.00. Following the completion of the transaction, the executive vice president owned 53,518 shares of the company's stock, valued at $8,231,603.58. This represents a 38.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 133,774 shares of company stock valued at $20,415,519 over the last three months. Company insiders own 2.11% of the company's stock.

Globe Life Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be given a $0.33 dividend. The ex-dividend date is Monday, July 6th. This represents a $1.32 annualized dividend and a yield of 0.9%. Globe Life's dividend payout ratio (DPR) is currently 9.13%.

About Globe Life

(Get Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Globe Life Right Now?

Before you consider Globe Life, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.

While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines